Business Context and Reporting Period
Company: ALPHA MODUS HOLDINGS, INC. (AMOD)
Filing Type: Form 8-K (Current Report)
Date of Report: April 28, 2025
Reporting Period: Events occurring on April 28, 2025
The Company, an emerging growth company, reported the entry into material definitive agreements regarding patent litigation funding and the amendment of a secured convertible promissory note.
Key Financial Metrics and Agreements
This filing details specific contractual obligations rather than standard periodic financial performance metrics (e.g., revenue, net income). Key financial terms include:
- Debt Obligation: The outstanding balance of the Secured Convertible Promissory Note with Streeterville Capital, LLC was increased to $3,597,501.71 as of April 28, 2025.
- Monthly Payments: The Company is obligated to make monthly payments of $582,000 plus all accrued but unpaid interest under the amended Note.
- Equity Issuance: The Company agreed to sell 1,250,000 shares of common stock ("Pre-Delivery Shares") to the Investor for $125.
- Option Exercise Price: Under the Option Agreement to acquire Alpha Modus Ventures, LLC (AMV), the Company may pay $300,000 in cash and issue shares valued at $35,000,000 (based on closing price) upon shareholder approval.
- Litigation Funding: The Company agreed to fund litigation for AMV against Broadcom Inc., with gross proceeds distributed to the Company first to recoup funding, followed by tiered percentages (65%, 45%, 35%) until specific return multiples are achieved.
Material Changes Versus Prior Period
The filing outlines significant modifications to a debt instrument originally entered into in October 2024 and amended in December 2024 and January 2025:
- Prepayment Penalty: The 20% prepayment penalty was eliminated; however, the principal balance was immediately increased by the amount of the penalty that would have been due ($3,597,501.71 total).
- Payment Terms: Monthly payment obligations increased from $485,000 (plus interest) to $582,000 (plus interest).
- Conversion Floor: The conversion floor price for the Note was reduced from $4.00 per share to $1.25 per share.
- Extension Rights: The Company gained the right to extend the monthly payment start date up to three times, with the outstanding balance increasing by 1% for each extension.
- Ownership Cap: The Investor's beneficial ownership limitation was increased to 9.99%.
Guidance, Outlook, Risks, and Contingencies
Management Commentary and Outlook: The Company is pursuing a patent monetization strategy involving litigation against Broadcom Inc. regarding fiber channel data transport patents. The Company has secured consent from its primary creditor (Streeterville Capital) to proceed with this strategy.
Risks and Contingencies:
- Litigation Risk: Future cash flows from the Patent Monetization Agreement are contingent upon the success of the lawsuit against Broadcom Inc.
- Liquidity Risk: The Company faces significant monthly cash outflows ($582,000 plus interest) starting May 16, 2025, unless extended.
- Dilution Risk: The Option Agreement involves the potential issuance of shares valued at $35,000,000, subject to shareholder approval and Nasdaq listing rules.
- Shareholder Approval: The Company must hold a stockholder meeting within 60 days to approve issuances to the Investor under the Note and future equity line of credit agreements exceeding the Exchange Cap.
Important Facts for Investor Verification
- Verify the Company's ability to meet the new monthly payment obligation of $582,000 plus interest starting May 16, 2025.
- Confirm the status of the shareholder meeting required within 60 days to approve the issuance of Pre-Delivery Shares and other convertible securities.
- Monitor the progress of the patent litigation against Broadcom Inc., as this is the primary source of potential future revenue under the new monetization agreement.
- Review the full text of the Second Amendment to the Note (Exhibit 10.3) for detailed terms regarding the 1% balance increase per extension.
- Assess the impact of the reduced conversion floor price ($1.25) on potential future dilution.